Anticonvulsants in bipolar disorder

Psychiatric Clinics of North America

Volumn 28, Issue 2, 2005, Pages 301-323

  Singh, Vivek ^a   Muzina, David J ^b   Calabrese, Joseph R ^c,d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETAZOLAMIDE; AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ARIPIPRAZOLE; CALCIUM CHANNEL; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CLOZAPINE; ETIRACETAM; GABAPENTIN; GLUTAMIC ACID; HALOPERIDOL; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PAROXETINE; PHENYTOIN; RISPERIDONE; SODIUM CHANNEL; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE; ZONISAMIDE;

AGRANULOCYTOSIS; ALOPECIA; ANOREXIA; ANXIETY DISORDER; APLASTIC ANEMIA; ARTHRALGIA; ATAXIA; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BODY WEIGHT; BODY WEIGHT DISORDER; BONE MARROW SUPPRESSION; CLINICAL TRIAL; COGNITIVE DEFECT; CONFUSION; CONSTIPATION; DEPRESSION; DIARRHEA; DIPLOPIA; DISEASE ASSOCIATION; DISEASE COURSE; DIZZINESS; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; EPILEPSY; ERYTHROPENIA; FATIGUE; GINGIVA HYPERPLASIA; HUMAN; HYPOMANIA; HYPONATREMIA; HYPOTHESIS; KINDLING; LEUKOPENIA; LIVER TOXICITY; LONG TERM CARE; MANIA; MOTOR COORDINATION; MOTOR DYSFUNCTION; NAUSEA; NEPHROLITHIASIS; NEURAL TUBE DEFECT; NONHUMAN; NYSTAGMUS; PANCREATITIS; PARESTHESIA; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; REVIEW; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SLURRED SPEECH; SOMNOLENCE; STEVENS JOHNSON SYNDROME; THROMBOCYTOPENIA; TREMOR; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

EID: 17044404525     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2005.02.004     Document Type: Review

References (69)

1. K.N. Chengappa, S. Gerhson, and J. Levine The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder Bipolar Disord 3 5 2001 215 232
2. R.M. Post, and T.W. Uhde Treatment of mood disorder with antiepileptic medications: clinical and theoretical implications Epilepsia 2 1983 S97 S108
3. P.W. Wang, T.A. Ketter, and O.V. Becker New anticonvulsant medication uses in bipolar disorder CNS Spectr 12 2003 941 947
4. P.A. Lambert, G. Cavaz, and S. Borselli Action neuropsychotrope d'un nouvel anti-epileplique: le depamide Ann Med Psychol 1 1966 707 710
5. H.M. Emrich, D.K.W. von Zerssen, and H.J. Moller On a possible role of GABA in mania: therapeutic efficacy of sodium valproate Adv Biochem Psychopharmacol 26 1981 287 296
6. H.G. Pope Jr., S.L. McElroy, and P.E. Keck Jr. Valproate in the treatment of acute mania: a placebo-controlled study Arch Gen Psychiatry 48 1991 62 68
7. C.L. Bowden Efficacy of divalproex vs lithium and placebo in mania JAMA 272 1994 1005 1006
8. P.E. McElroy, S.L. Keck, and K.C. Tugrul Valproate as a loading treatment in acute mania Neuropsychobiology 27 1993 146 149
9. C.L. Bowden, J.R. Calabrese, and B.A. Wallin Illness characteristics of patients in clinical drug studies of mania Psychopharmacol Bull 31 1 1995 103 109
10. A.C. Swann, C.L. Bowden, and D. Morris Depression during mania: treatment response to lithium or divalproex Arch Gen Psychiatry 54 1997 37 42
11. T.W. Freeman, J.L. Clothier, and P. Pazzaglia A double-blind comparison of valproate and lithium in the treatment of acute mania Am J Psychiatry 149 1992 108 111
12. J.M. Zajecka, R. Weisler, and G. Sachs A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder J Clin Psychiatry 63 12 2002 1148 1155
13. M. Tohen, T.A. Ketter, and C.A. Zarate Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study Am J Psychiatry 160 2003 1263 1271
14. G. Sachs, F. Grossman, and A. Okamoto Risperidone plus mood stabilizer versus placebo plus mood stabilizer for acute mania of bipolar disorder: a double-blind comparison of efficacy and safety Am J Psychiatry 159 2002 1146 1154
15. L.N. Yatham, F. Grossman, and I. Augustyns Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial Br J Psychiatry 182 2003 141 147
16. B. Muller-Oerlinghausen, A. Retzow, and F.A. Henn Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study J Clin Psychopharmacol 20 2 2000 195 203
17. L.T. Young, R.T. Joffe, and J.C. Robb Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression Am J Psychiatry 157 1 2000 124 126
18. C.L. Bowden Valproate Bipolar Disord 5 3 2003 189 202
19. Sachs G, Altshuler L, Ketter T, et al. Divalproex versus placebo for the treatment of bipolar depression. Presented at the 40th Annual Meeting of the American College of Neuropsychopharmacology. Waikoloa, Hawaii, December 9-13, 2001.
20. L.L. Davis, D. Kabel, and D. Patel Valproate as an antidepressant in major depressive disorder Psychopharmacol Bull 32 4 2004 647 652
21. F. Petty, L.L. Davis, and A.L. Nugent Valproate therapy for chronic, combat-induced posttraumatic stress disorder J Clin Psychopharmacol 22 1 2002 100 101
22. L. Gyulai, C.L. Bowden, and S.L. McElroy Maintenance efficacy of divalproex in the prevention of bipolar depression Neuropsychopharmacology 28 7 2003 1374 1382
23. C.L. Bowden, J.R. Calabrese, and S.L. McElroy A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder Arch Gen Psychiatry 57 2000 481 489
24. C.L. Bowden, P.G. Janicak, and P. Orsulak Relationship of serum valproate concentration to response in mania Am J of Psychiatry 153 6 1996 765 770
25. D.J. Luchins, D. Klass, and P. Hanrahan Computerized monitoring of valproate and physician responsiveness to laboratory studies as a quality indicator Psychiatr Serv 51 9 2000 1179 1181
26. C.L. DeVane Pharmacokinetics, drug interactions, and tolerability of valproate Psychopharmacol Bull 37 S2 2003 25 42
27. S. Acharya, and J.B. Bussel Hematologic toxicity of sodium valproate J Pediatr Hematol Oncol 22 1 2000 62 65
28. T.A. Ketter, P.W. Wang, and R.M. Post Carbamazepine and oxcarbazepine A. Schatzberg C. Nemeroff Textbook of psychopharmacology 1998 American Psychiatric Publishing Washington (DC) 581 606
29. P.E. Keck Jr., J. Mendlwicz, and J.R. Calabrese A review of randomized, controlled clinical trials in acute mania J Affect Disord 59 S1 2000 S31 S37
30. R.H. Weisler, A.H. Kalali, T.A. Ketter, and SPD 417 Study Group A multicenter, randomized, double-blind, placebo-controlled trial of extended release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes J Clin Psychiat 65 4 2004 478 484
31. J.C. Ballenger, and R.M. Post Carbamazepine in manic-depressive illness: a new treatment Am J Psychiatry 137 7 1980 782 790
32. C.L. Ernst, and J.F. Goldberg Antidepressant properties of anticonvulsant drugs for bipolar disorder J Clin Psychopharmacol 23 2 2003 182 192
33. R.M. Post, T.W. Uhde, and P.P. Roy-Byrne Antidepressant effects of carbamazepine Am J Psychiatry 143 1 1986 29 34
34. R.M. Post, K.D. Denicoff, and M.A. Frye Re-evaluating carbamazepine prophylaxis in bipolar disorder Br J Psychiatry 170 1997 202 204
35. T. Okuma, K. Inanage, and S. Otsuki A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness Psychopharmacology (Berl) 73 1981 95 96
36. W. Greil, N. Kleindienst, and N. Erazo Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder J Clin Psychopharmacol 18 6 1998 455 460
37. C.L. Bowden Acute and maintenance treatment with mood stabilizers Int J Neuropsychopharmacol 6 2003 269 275
38. K.D. Denicoff, E.E. Smith-Jackson, and E.R. Disney Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder J Clin Psychiatry 58 11 1997 470 478
39. J.S. Hellewell Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: review of efficacy and tolerability J Affect Disord 72 S1 2002 S23 S34
40. H.M. Emrich Studies with oxcarbazepine in acute mania Int Clin Psychopharmacol S5 1990 83 88
41. Trileptal [package insert] 2000 Novartis Pharmaceuticals Corp East Hanover, NJ
42. D.J. Muzina, S. El-Sayegh, and J.R. Calabrese Antiepileptic drugs in psychiatry-focus on randomized controlled trial Epilepsy Res 50 1-2 2002 195 202
43. Physicians' Desk Reference 59th edition 2005 Thomson PDR Montvale (NJ)
44. J.A. Van Parys, and H. Meinardi Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis Epilepsy Res 19 1 1994 79 85
45. Bowden C, Calabrese R, Ascher J, et al. Spectrum of efficacy of lamotrigine in bipolar disorder: overview of double-blind, placebo-controlled studies. Abstracts of the 2000 Annual Meeting of the American College of Neuropsychopharmacology (ACNP). Nashville, TN: ACNP.
46. C.L. Bowden Lamotrigine in the treatment of bipolar disorder Expert Opin Pharmacother 10 2002 1513 1519
47. J.R. Calabrese, C.L. Bowden, and G.S. Sachs A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression J Clin Psychiatry 60 1999 79 88
48. M.A. Frye, T.A. Ketter, and T.A. Kimbrell A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders J Clin Psychopharmacol 20 2000 607 614
49. C.L. Bowden, J.R. Calabrese, and G. Sachs A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder Arch Gen Psychiatry 60 2003 392 400
50. J.R. Calabrese, C.L. Bowden, and G. Sachs A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar i disorder J Clin Psychiatry 64 2003 1013 1024
51. J.R. Calabrese, E. Vieta, and M.D. Shelton Latest maintenance data on lamotrigine in bipolar disorder Eur Neuropsychopharmacol 13 2003 S57 S66
52. J.R. Calabrese, T. Suppes, and C.L. Bowden A double-blind placebo-controlled prophylaxis study of lamotrigine in rapid cycling bipolar disorder J Clin Psychiatry 61 2000 841 850
53. Lamictal [package insert] 2003 GlaxoSmithKline Research Triangle Park. NC
54. M.C. Cunnington The International Lamotrigine Pregnancy Registry Update for the Epilepsy Foundation Epilepsia 45 11 2004 1468
55. B. Gidal, W. Garnett, and N. Graves Epilepsy J. Dipiro R.L. Talbert G. Yee Pharmacotherapy - a pathophysiologic approach 2002 McGraw-Hill New York, NY 1031 1036
56. S. McElroy, and P.E. Keck Jr. Topiramate A. Schatzberg C. Nemeroff Textbook of chopharmacology 1998 American Psychiatric Publishing Washington (DC) 627 636
57. R.S. McIntyre, D.A. Mancini, and S. McCann Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study Bipolar Disord 4 3 2002 207 213
58. E. Vieta, J.M. Goikolea, and J.M. Olivares 1-year follow-up of patients treated with risperidone and topiramate for a manic episode J Clin Psychiatry 64 7 2003 834 839
59. M. Frye Gabapentin A. Schatzberg C. Nemeroff Textbook of psychopharmacology 1998 American Psychiatric Publishing Washington (DC) 607 613
60. A.C. Pande, J.G. Crockatt, and C.A. Janney Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group Bipolar Disord 2 3 Pt 2 2000 249 255
61. A.C. Pande, J.R. Davidson, and J.W. Jefferson Treatment of social phobia with gabapentin: a placebo-controlled study J Clin Psychopharmacol 19 4 1999 341 348
62. S. Kanba, G. Yagi, and K. Kamijima The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania Prog Neuropsychopharmacol 18 4 1994 707 715
63. K.M. Gadde, D.M. Franciscy, and H.R. Wagner II Zonisamide for weight loss in obese adults: a randomized controlled trial JAMA 289 14 2003 1820 1825
64. K. Kaufman Monotherapy treatment of bipolar disorder with levetiracetam Epilepsy Behav 5 6 2004 1017 1020
65. H. Grunze, J. Langosch, and C. Born Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design J Clin Psychiatry 64 7 2003 781 784
66. J.H. Fischer, T.V. Patel, and P.A. Fischer Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures Clin Pharmacokinet 42 1 2003 33 58
67. L.B. Kalinowsky, and T.J. Putnam Attempts at treatment of schizophrenia and other non-epileptic psychoses with Dilantin Arch Neurol Psychiatry 49 1943 414 420
68. A. Mishory, Y. Yaroslavsky, and Y. Bersudsky Phenytoin as an antimanic anticonvulsant: a controlled study Am J Psychiatry 157 3 2000 463 465
69. J. Applebaum, J. Levine, and R.H. Belmaker Intravenous fosphenytoin in acute mania J Clin Psychiatry 64 4 2003 408 409